Clinical Trials · NCT05131893
Neoadjuvant Treatment of Breast Cancer
- Phase
- N/A
- Recruitment status
- Not Yet Recruiting
- Sponsor
- National Institute of Oncology, Hungary
- Enrollment
- 300
- Start date
- Mar 2022
- Locations
- 1 site, Hungary
- Primary endpoint
- pathological complete remission rate